As of 1 Nov 2026, Sci2sci has raised $1.3M across 1 verified round on record (amounts in other currencies converted to USD); latest: €1.2 million pre-seed round led by Heliad and IBB Ventures, announced 8 Sep 2026.
AI Trustworthy for Biopharma
sci2sci.comBerlin, GermanyAI
6 sources
The article date displays 09/08/2026, while the dateline states 08.09.2026; the dateline fixes the announcement date as 2026-09-08.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Pre-seed [ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $1.3M €1.2 million | 2026-09-08 | Heliad, IBB Ventures | No recent discussion |
6 sources [ VERIFIED · CORRECTED ] read against 1 of 6 sources
The article date displays 09/08/2026, while the dateline states 08.09.2026; the dateline fixes the announcement date as 2026-09-08. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]6 pages read: tech.eu, startupvalley.news, finsmes.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 of 6 sources·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
sci2sci builds VectorCat and Integrity Cortex, software for biotech, pharma and other regulated companies that connects scattered data and makes AI outputs traceable and verifiable.
Biopharma research and regulatory data is scattered across PDFs, spreadsheets, lab notes and disconnected systems, so humans can spend weeks verifying evidence chains while AI layered on inconsistent data can hallucinate with confidence. The €1.2 million pre-seed is funding engineering and deployments of VectorCat and Integrity Cortex across reported customers in preclinical research, contract clinical research and bioprocess operations, while sci2sci bets that a neurosymbolic verification layer can make every AI claim traceable in regulated workflows.